Fisher Asset Management, LLC - INTEGRA LIFESCIENCES HLDGS C ownership

INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 223 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Fisher Asset Management, LLC ownership history of INTEGRA LIFESCIENCES HLDGS C
ValueSharesWeighting
Q3 2023$17,964,843
-22.8%
470,407
-16.9%
0.01%
-23.1%
Q2 2023$23,283,569
-26.5%
566,097
+2.6%
0.01%
-31.6%
Q1 2023$31,689,344
+97951.7%
551,983
-4.2%
0.02%
-13.6%
Q4 2022$32,319
-99.9%
576,396
-0.0%
0.02%
+22.2%
Q3 2022$24,424,000
-21.8%
576,580
-0.2%
0.02%
-18.2%
Q2 2022$31,228,000
-18.4%
577,979
-2.9%
0.02%
-4.3%
Q1 2022$38,263,000
-5.1%
595,440
-1.1%
0.02%0.0%
Q4 2021$40,331,000
-3.4%
602,051
-1.2%
0.02%
-11.5%
Q3 2021$41,741,000
-3.5%
609,534
-3.9%
0.03%
-3.7%
Q2 2021$43,276,000
-2.8%
634,172
-1.6%
0.03%
-12.9%
Q1 2021$44,507,000
+1.3%
644,182
-4.8%
0.03%
-6.1%
Q4 2020$43,935,000
+38.3%
676,754
+0.6%
0.03%
+17.9%
Q3 2020$31,764,000
-0.5%
672,671
-1.0%
0.03%
-9.7%
Q2 2020$31,926,000
+0.4%
679,430
-4.6%
0.03%
-20.5%
Q1 2020$31,804,000
-21.8%
711,982
+2.0%
0.04%
-4.9%
Q4 2019$40,663,000
-7.0%
697,710
-4.2%
0.04%
-14.6%
Q3 2019$43,734,000
+0.2%
728,058
-6.8%
0.05%0.0%
Q2 2019$43,628,000
-49.2%
781,166
-54.6%
0.05%
-11.1%
Q1 2019$85,856,000
+101.3%
1,721,087
+82.0%
0.05%
-6.9%
Q4 2018$42,647,000
-31.2%
945,619
+0.6%
0.06%
-22.7%
Q3 2018$61,947,000
+1.6%
940,440
-0.6%
0.08%
-5.1%
Q2 2018$60,946,000
+15.1%
946,217
-1.1%
0.08%
+12.9%
Q1 2018$52,951,000
+11.2%
956,830
-3.9%
0.07%
+12.9%
Q4 2017$47,639,000
-6.1%
995,390
-1.0%
0.06%
-12.7%
Q3 2017$50,745,000
-7.8%
1,005,255
-0.5%
0.07%
-14.5%
Q2 2017$55,058,000
+26.7%
1,010,060
-2.1%
0.08%
+18.6%
Q1 2017$43,449,000
-2.9%
1,031,310
+97.8%
0.07%
-10.3%
Q4 2016$44,725,000
+2.9%
521,330
-1.0%
0.08%
+1.3%
Q3 2016$43,455,000
+7.2%
526,405
+4.6%
0.08%
+2.7%
Q2 2016$40,521,000
+11.2%
503,365
-7.6%
0.08%
+8.7%
Q1 2016$36,437,000
-2.6%
544,895
-1.3%
0.07%
-4.2%
Q4 2015$37,428,000
+13.9%
552,195
+0.1%
0.07%
+5.9%
Q3 2015$32,847,000
-5.2%
551,595
+7.2%
0.07%
+1.5%
Q2 2015$34,667,000
+8.1%
514,582
-1.1%
0.07%
+4.7%
Q1 2015$32,070,000
+10.1%
520,200
-3.2%
0.06%
+6.7%
Q4 2014$29,128,000
+6.9%
537,125
-2.2%
0.06%
+3.4%
Q3 2014$27,253,000
+8.8%
549,015
+3.2%
0.06%
+9.4%
Q2 2014$25,047,000
-5.2%
532,225
-7.3%
0.05%
-11.7%
Q1 2014$26,408,000
-5.4%
574,215
-1.9%
0.06%
-4.8%
Q4 2013$27,921,000
+14.2%
585,215
-3.7%
0.06%
+5.0%
Q3 2013$24,452,000
+10.1%
607,515
+0.2%
0.06%
+3.4%
Q2 2013$22,213,000606,4150.06%
Other shareholders
INTEGRA LIFESCIENCES HLDGS C shareholders Q2 2017
NameSharesValueWeighting ↓
VeriStar Capital Management LP 268,000$10,234,9208.72%
Madison Avenue Partners, LP 964,667$36,840,6335.23%
Pavadi Capital LLC 99,999$3,818,9624.97%
KESTREL INVESTMENT MANAGEMENT CORP 122,450$4,6762.96%
Sapience Investments, LLC 245,700$9,383,2832.26%
Ellsworth Advisors, LLC 102,500$3,882,7001.38%
Point72 Europe (London) LLP 464,462$17,737,8041.09%
COOKE & BIELER LP 2,714,194$103,655,0691.01%
TANDEM CAPITAL MANAGEMENT CORP /ADV 75,586$2,886,6300.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,126,827$43,033,5230.95%
View complete list of INTEGRA LIFESCIENCES HLDGS C shareholders